INVIA

About INVIA

INVIA sits in Software & AI, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Reuters Health · 2026-09-28
  Invia expands cyclotron capacity to meet Lu-177 demand
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Endpoints News · 2026-02-07
  Invia announces Phase II readout for lead theranostic candidate
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• FierceBiotech · 2026-03-14
  Invia appoints new Chief Medical Officer ahead of pivotal trial
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.